Bisaryl heterocycles as NRF2 activators

Assignee

• Glaxosmithkline Intellectual Property Development Limited

Inventors

• James Francis Callahan (60 patents)
• Roderick S. Davis (5 patents)
• Nicole Cathleen Goodwin (13 patents)
• Jeffrey K. Kerns (17 patents)

View full patent text on Google Patents →